Cargando…

Administration of thiamazole for Graves’ disease might trigger the onset of type 1 diabetes

Thiamazole might trigger the onset of type 1 diabetes. [Image: see text]

Detalles Bibliográficos
Autores principales:	Mizutani, Gen, Hikima, Yusuke, Satomura, Atsushi, Iuchi, Takujiro, Nakajima, Ritsuko, Miyashita, Yumi, Yasuda, Shigemitsu, Oikawa, Yoichi, Isshiki, Masashi, Inoue, Ikuo, Noda, Mitsuhiko, Shimada, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123042/ https://www.ncbi.nlm.nih.gov/pubmed/29900683 http://dx.doi.org/10.1111/jdi.12784

Ejemplares similares

Weight control before and during pregnancy for patients with gestational diabetes mellitus
por: Yasuda, Shigemitsu, et al.
Publicado: (2019)

Clinical characterization of patients with primary aldosteronism plus subclinical Cushing’s syndrome
por: Yasuda, Shigemitsu, et al.
Publicado: (2020)

HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report
por: Yasuda, Shigemitsu, et al.
Publicado: (2023)

Bodyweight threshold for sudden onset of ketosis might exist in ketosis‐prone type 2 diabetes patients
por: Satomura, Atsushi, et al.
Publicado: (2019)

Simultaneous development of Graves’ disease and type 1 diabetes during anti‐programmed cell death‐1 therapy: A case report
por: Kurihara, Susumu, et al.
Publicado: (2020)

Thiamazol-induzierte Arthritis
por: Brinkman, Antonia, et al.
Publicado: (2020)

Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment
por: Tsukada, Daichi, et al.
Publicado: (2022)

Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes
por: Sakai, Gota, et al.
Publicado: (2018)

Effect of thiamazole on kainic acid-induced seizures in mice
por: Feng, Jigao, et al.
Publicado: (2021)

Examination of Malignant Findings of Thyroid Nodules Using Thyroid Ultrasonography
por: Saito, Daigo, et al.
Publicado: (2020)

Familial Dysalbuminemic Hyperthyroxinemia that was Inappropriately Treated with Thiamazole Due to Pseudo-thyrotoxic Symptoms
por: Fukaishi, Takahiro, et al.
Publicado: (2017)

Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly
por: Yasuda, Shigemitsu, et al.
Publicado: (2021)

Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
Publicado: (2022)

Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
por: Alvarez-Gamero, Julio César, et al.
Publicado: (2022)

Efficacy and Clinical Characteristics of Liraglutide in Japanese Patients With Type 2 Diabetes
por: Ito, Daisuke, et al.
Publicado: (2015)

Syringe Paper-Based Analytical Device for Thiamazole Detection by Hedysarum Polysaccharides-Mediated Silver Nanoparticles
por: Liu, Dan, et al.
Publicado: (2023)

Real‐world risk of lower‐limb amputation associated with sodium–glucose cotransporter 2 inhibitors versus metformin: A propensity score‐matched model analysis in Japan
por: Mizutani, Gen, et al.
Publicado: (2022)

Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report
por: Satomura, Atsushi, et al.
Publicado: (2021)

On‐label use of sodium–glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes
por: Horii, Takeshi, et al.
Publicado: (2021)

Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report
por: Shen, Chuan, et al.
Publicado: (2010)

Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational Study
por: Sugawa, Sayaka Wakabayashi, et al.
Publicado: (2021)

Fetal and Neonatal Goiter in Cynomolgus Monkeys Following Administration of the Antithyroid Drug Thiamazole at High Doses to Dams During Pregnancy
por: Yoshikawa, Tsuyoshi, et al.
Publicado: (2011)

Goiter at Diagnosis Might Be Predicting Factor for Early Onset Intractable Graves’ Disease
por: Kim, Sungeun, et al.
Publicado: (2021)

Serum 25-hydroxyvitamin D might be an independent prognostic factor for Graves disease recurrence
por: Ahn, Hwa Young, et al.
Publicado: (2017)

Thyroid storm associated with Graves' disease covered by diabetic ketoacidosis: A case report
por: Osada, Erika, et al.
Publicado: (2011)

Combination of anti‐CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as ‘pregnancy‐related’ type 1 diabetes model
por: Shimada, Akira, et al.
Publicado: (2022)

Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
por: Choi, Yun Mi, et al.
Publicado: (2019)

Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study
por: Sekizaki, Tomonori, et al.
Publicado: (2021)

Luminal plant sterol promotes brush border membrane-to-lumen cholesterol efflux in the small intestine
por: Nakano, Takanari, et al.
Publicado: (2018)

A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves' Disease with Methimazole
por: Miyashita, Kazuyuki, et al.
Publicado: (2013)

Serum vitamin D levels are decreased in patients without remission of Graves’ disease
por: Yasuda, Tetsuyuki, et al.
Publicado: (2012)

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)
por: Awata, Takuya, et al.
Publicado: (2017)

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus
por: Ihana-Sugiyama, Noriko, et al.
Publicado: (2017)

THU671 Genes Encoding Adaptive Immune Receptor Repertoire Might Be Associated With The Risk Of Graves’ Disease And Antithyroid Drug-induced Agranulocytosis
por: Jui Huang, Chun, et al.
Publicado: (2023)

Long-Term Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: 104-Week Follow-up of an Open-Label Study
por: Ito, Daisuke, et al.
Publicado: (2018)

Relationship between the Plasma Levels of Catecholamines and Return of Spontaneous Circulation in Patients with Out-of-Hospital Cardiac Arrest
por: Ichikawa, Yumi, et al.
Publicado: (2021)

Influence of the prehospital administered dosage of epinephrine on the plasma levels of catecholamines in patients with out-of-hospital cardiac arrest
por: Nakajima, Jun, et al.
Publicado: (2021)

Efficacy of the treatment for elderly emergency patients with sepsis
por: Isshiki, Yuta, et al.
Publicado: (2021)

The long-term coronary heart disease risk of previously obese patients with type 2 diabetes mellitus
por: Yamamoto-Honda, Ritsuko, et al.
Publicado: (2013)

HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019
por: Yanagisawa, Shinnosuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e74qldgqlucj1e1p460ramfm1l